Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Mohs Surgery Effective for Atypical Fibroxanthoma

J Am Acad Dermatol; ePub 2018 Jul 5; Tolkachjov, et al

Mohs micrographic surgery (MMS) for atypical fibroxanthoma (AFX)—a fibrohistiocytic tumor with relatively high local recurrence rates, but low metastatic potential—is associated with a lower recurrence rate than wide local excision (WLE), a recent study found. Researchers sought to systematically review evidence of AFX recurrence and metastatic rates following different surgical modalities. They conducted a comprehensive literature search from 1946, or database inception, to March 20, 2017. 23 studies were selected (907 patients and 914 tumors). 175 cases were treated with MMS (recurrence rate, 2.0%; metastatic rate, 1.9%). 732 were treated with WLE (recurrence rate, 8.7; metastasis rate, 1%). Researchers found that among immunocompromised patients, no recurrence or metastases developed in the MMS subgroup, whereas 4 out of 10 recurred and 1 out of 10 metastasized in the WLE subgroup.

Citation:

Tolkachjov SN, Kelley BF, Alahdab F, Erwin PJ, Brewer JD. Atypical fibroxanthoma: Systematic review and meta-analysis of treatment with Mohs micrographic surgery or excision. [Published online ahead of print July 5, 2018]. J Am Acad Dermatol. doi:10.1016/j.jaad.2018.06.048.

This Week's Must Reads

Dietary Changes: No Major Effect on Psoriasis, Dermatol Online J; 2019 Feb 15; Pona, et al

Influenza Vaccine Rates in Adults with Psoriasis, J Invest Dermatol; 2019 Feb; Noe, Shin, et al

Psoriasis and AD Share Inflammatory Components, J Invest Dermatol; ePub 2019 Jan 11; Tsoi, et al

Quality of Life Among Patients with Psoriasis, PsA, Arch Dermatol Res; ePub 2019 Mar 13; Duvetorp, et al

Psoriasis and Cardiometabolic Comorbidity in Women, Acta Derm Venereol; 2019 Mar 1; Blegvad, et al

Must Reads in Dermatologic Surgery

Lymph Node Ratio and Survival Post-MCC Surgery, JAMA Dermatol; ePub 2019 Mar 2; Cheraghlou, et al

Nonsterile Gloves Safe for Skin Cancer Excisions, J Cosmet Dermatol; ePub 2019 Jan 20; Michener, et al

Patient Communication Assessed Post-Mohs Surgery, Dermatolog Surg; ePub 2019 Jan 11; Chitgopeker, et al

Mohs Surgery Beneficial for Melanoma of Head/Neck, Dermatolog Surg; ePub 2018 Dec 13; Demer, et al

DOT Laser Offers Low Incidence of Adverse Effects, J Drugs Dermatol; 2018 Nov; Sarnoff, Gotkin, et al